Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent influenza split vaccine in healthy subjects aged 3–60 years
CTR20160364Phase 3Completed
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Jul 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Quadrivalent influenza split vaccine (Changchun Sponsor Institute of Biological Products) in influenza, sponsored by Wuhan Institute of Biological Products. Started Jul 2016; status: completed.
02
Drugs
Quadrivalent influenza split vaccine (Changchun Sponsor Institute of Biological Products)
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20160364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160364.